Assessing and modifying cardiovascular risk in people who present to a chest pain clinic with non-cardiac causes

Johannes T Neumann^{1

2}, Andrew M Tonkin¹

Affiliations

Editorial

Johannes T Neumann et al. Med J Aust. 2021 Apr.

. 2021 Apr;214(6):263-264.

doi: 10.5694/mja2.50984. Epub 2021 Mar 8.

Johannes T Neumann^{1

2}, Andrew M Tonkin¹

No abstract available

Keywords: Absolute risk; Coronary artery disease; Education; Prevention and control; Risk factors; public health.

Comment on

Absolute risk assessment for guiding cardiovascular risk management in a chest pain clinic.
Black JA, Campbell JA, Parker S, Sharman JE, Nelson MR, Otahal P, Hamilton G, Marwick TH. Black JA, et al. Med J Aust. 2021 Apr;214(6):266-271. doi: 10.5694/mja2.50960. Epub 2021 Feb 23. Med J Aust. 2021. PMID: 33622026 Clinical Trial.

1. Neumann JT, Twerenbold R, Ojeda F, et al. Application of high-sensitivity troponin in suspected myocardial infarction. N Engl J Med 2019; 380: 2529-2540.
1. Chew DP, Scott IA, Cullen L, et al; NHFA/CSANZ ACS Guideline 2016 Executive Working Group. National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016. Heart Lung Circ 2016; 25: 895-951.
1. Collet JP, Thiele H, Barbato E, et al; ESC Scientific Document Group. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2020; https://doi.org/10.1093/eurheartj/ehaa575 [online ahead of print].
1. Black JA, Campbell JA, Parker S, et al. Absolute risk assessment for guiding cardiovascular risk management in a chest pain clinic. Med J Aust 2021; 214: 266-271.
1. Klimis H, Chow CK. Are we behind the times on cardiovascular risk assessment in Australia? Med J Aust 2020; 213: 168-169. https://www.mja.com.au/journal/2020/213/4/are-we-behind-times-cardiovasc...